Comparing Virtual Reality Immersion to Midazolam Premedication for Reducing Anxiety in Adults Undergoing Dacryocystorhinostomy Surgery

What this Trial Is About

This research aims to compare the effects of virtual reality immersion versus midazolam premedication on anxiety and blood pressure stability in adult patients undergoing dacryocystorhinostomy DCR surgery under general anesthesia. DCR is a procedure to bypass blocked tear ducts, and preoperative anxiety is common due to fears related to surgery and its outcomes. Midazolam is commonly used to reduce anxiety but has side effects and debated benefits, while virtual reality offers a non-drug alternative to ease anxiety. Participants will be randomly assigned to one of two groups one will experience virtual reality immersion using an Oculus device, and the other will receive midazolam medication before surgery. The study does not mask treatments and compares these approaches directly. The surgery and anesthesia procedures will follow standard care, with the interventions applied prior to the operation. Throughout the study, researchers will measure anxiety levels 15 minutes after the intervention and monitor heart rate and blood pressure for up to two hours after intubation. They will also assess patient satisfaction two hours after the intervention and track any complications within 30 minutes after the breathing tube is removed. The study will enroll adults aged 18 to 65 and continue until December 2025.

Anxiolytic Effect of Virtual Reality Immersion Versus Midazolam Premedication in Patients Undergoing Dacryocystorhinostomy Surgery